COMMUNIQUÉS West-GlobeNewswire

Celularity’s Strategic Partner Announces Groundbreaking for State-of-the-Art Stem Cell & Regenerative Medicine Center in Asia Pacific

20/11/2024 - 14:30

Celularity is collaborating with its strategic partner, Genting Berhad, to bring Celularity placenta-derived allogeneic stem cell therapeutics to the Asia Pacific region Genting Berhad announced groundbreaking on a new [...]

Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference

20/11/2024 - 14:30

MALVERN, Pa., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who [...]

Silexion Therapeutics to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference

20/11/2024 - 14:30

GRAND CAYMAN, CAYMAN ISLANDS, Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven cancers, today announced that [...]

StoryCatch Partners Acquires EmpiraMed

20/11/2024 - 14:43

Combined organization will unlock patterns in complex participant populations, driving physical and mental health improvement WELLESLEY HILLS, Mass., Nov. 20, 2024 (GLOBE NEWSWIRE) -- StoryCatch Partners , a Public [...]

Northwell Health Cancer Institute Launches Patient Enrollment in RenovoRx’s Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial

20/11/2024 - 14:45

The Northwell Health Cancer Institute is the Most Recent Clinical Site to Join the TIGeR-PaC Study, and RenovoRx Aims to Reach Full Patient Enrollment in the First Half of 2025 Phase III Clinical Trial is Evaluating the [...]

Capricor Therapeutics Granted Orphan Drug and ATMP Status for Deramiocel by European Medicines Agency

20/11/2024 - 15:00

Milestone represents a significant step forward in the development of deramiocel for the treatment of Duchenne muscular dystrophy in the European region SAN DIEGO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics [...]

KOELIS announces the first interim results of the VIOLETTE trial which evaluates the use of OBT-Fusion® technology in focal ablation of the prostate by microwave needles

20/11/2024 - 15:00

GRENOBLE, France, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com ), a global leader and innovator in prostate care, announced today passing an important milestone demonstrating [...]

CirrusMD Receives FedRAMP® Moderate Authorization for Virtual Care Solution

20/11/2024 - 15:00

Authorization demonstrates CirrusMD's commitment to securely serving Veterans with Virtual Health Chat for Government DENVER, Nov. 20, 2024 (GLOBE NEWSWIRE) -- CirrusMD, creator of the Physician-first Care & [...]

PeopleOne Health and RosenCare Celebrate Opening of Fourth Health Center in Central Florida

20/11/2024 - 15:00

New Orlando facility advances the team’s mission of transforming healthcare in Florida, improving access to quality health and wellness services ORLANDO, Fla. and PITTSBURGH, Nov. 20, 2024 (GLOBE NEWSWIRE) -- PeopleOne [...]

Zarminali Health Launches with $40M in Seed Funding to Transform Pediatric Care through Nationwide, Multi-specialty Practice Group

20/11/2024 - 15:00

New model for outpatient pediatric care combines seamlessly coordinated primary and specialty care with cutting-edge technology to transform the patient and family experience, and address physician burnout CHICAGO, Nov [...]

Sotera Health to Share Next Chapter of Growth at 2024 Investor Day

20/11/2024 - 15:00

CLEVELAND, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare [...]

Trading by management and close relations of management

20/11/2024 - 15:44

In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of [...]

Information relative au nombre total de droits de vote et d’actions composant le capital social

20/11/2024 - 16:11

Communiqué de Presse Dijon, le 20 novembre 2024 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe et commercialisera prochainement un portefeuille de médicaments dédiés aux situations d’ [...]

VITAS® Healthcare Honors Retired Hospice Veteran, Announces New Executive Leadership

20/11/2024 - 16:11

MIAMI, Nov. 20, 2024 (GLOBE NEWSWIRE) -- VITAS Healthcare, the nation’s leading provider of end-of-life care and a best-in-class healthcare employer , proudly announces four major executive leadership changes: Bob [...]

Guerbet annonce le lancement commercial en France d’Elucirem® (Gadopiclenol) son nouveau produit de contraste pour les examens d’imagerie par résonance magnétique (IRM).

20/11/2024 - 17:45

Guerbet annonce le lancement commercial en France d’Elucirem ® (Gadopiclenol) son nouveau produit de contraste pour les examens d’imagerie par résonance magnétique (IRM). Villepinte, le 20 novembre 2024 : Guerbet ( [...]

MAPS Successfully Clears Path for Cannabis Research through FDA Formal Dispute

20/11/2024 - 18:40

After three years of negotiation with the FDA, MAPS has successfully secured FDA clearance to conduct a clinical trial, MJP2, to examine the use of smoked cannabis for the treatment of PTSD symptoms among ~320 Veterans [...]

Court Filing against the Biden Administration’s Censorship Activities by the Association of American Physicians and Surgeons Educational Foundation Supports Its Expanded Allegations of Wrongdoing by the Federal Government

20/11/2024 - 18:44

TUCSON, Ariz., Nov. 20, 2024 (GLOBE NEWSWIRE) -- The Association of American Physicians and Surgeons Educational Foundation (“AAPS”) filed its reply in support of adding allegations against the censorship activities of [...]

LAPIX Therapeutics Announces Positive Topline Phase 1 Clinical Data Results with LPX-TI641 for the Treatment of Autoimmune Diseases

20/11/2024 - 19:00

LPX- TI641 is an oral novel Treg-expanding T cell/transmembrane, immunoglobulin, and mucin (Tim)receptor agonist therapy in development for the treatment of autoimmune diseases such as rheumatoid arthritis, psoriatic [...]

Nurix Therapeutics Receives PRIME Designation from the European Medicines Agency for NX-5948 for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia

20/11/2024 - 22:00

The PRIME initiative provides enhanced support to developers of promising medicines to optimize development plans and accelerate evaluation Pivotal trials of NX-5948 are planned to initiate in 2025 SAN FRANCISCO, Nov. [...]